TY - JOUR
T1 - Missense variants in ANKRD11 cause KBG syndrome by impairment of stability or transcriptional activity of the encoded protein
AU - de Boer, Elke
AU - Ockeloen, Charlotte W
AU - Kampen, Rosalie A
AU - Hampstead, Juliet E
AU - Dingemans, Alexander J M
AU - Rots, Dmitrijs
AU - Lütje, Lukas
AU - Ashraf, Tazeen
AU - Baker, Rachel
AU - Barat-Houari, Mouna
AU - Angle, Brad
AU - Chatron, Nicolas
AU - Denommé-Pichon, Anne-Sophie
AU - Devinsky, Orrin
AU - Dubourg, Christèle
AU - Elmslie, Frances
AU - Elloumi, Houda Zghal
AU - Faivre, Laurence
AU - Fitzgerald-Butt, Sarah
AU - Geneviève, David
AU - Goos, Jacqueline A C
AU - Helm, Benjamin M
AU - Kini, Usha
AU - Lasa-Aranzasti, Amaia
AU - Lesca, Gaetan
AU - Lynch, Sally A
AU - Mathijssen, Irene M J
AU - McGowan, Ruth
AU - Monaghan, Kristin G
AU - Odent, Sylvie
AU - Pfundt, Rolph
AU - Putoux, Audrey
AU - van Reeuwijk, Jeroen
AU - Santen, Gijs W E
AU - Sasaki, Erina
AU - Sorlin, Arthur
AU - van der Spek, Peter J
AU - Stegmann, Alexander P A
AU - Swagemakers, Sigrid M A
AU - Valenzuela, Irene
AU - Viora-Dupont, Eléonore
AU - Vitobello, Antonio
AU - Ware, Stephanie M
AU - Wéber, Mathys
AU - Gilissen, Christian
AU - Low, Karen J
AU - Fisher, Simon E
AU - Vissers, Lisenka E L M
AU - Wong, Maggie M K
AU - Kleefstra, Tjitske
N1 - Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2022/10
Y1 - 2022/10
N2 - PURPOSE: Although haploinsufficiency of ANKRD11 is among the most common genetic causes of neurodevelopmental disorders, the role of rare ANKRD11 missense variation remains unclear. We characterized clinical, molecular, and functional spectra of ANKRD11 missense variants.METHODS: We collected clinical information of individuals with ANKRD11 missense variants and evaluated phenotypic fit to KBG syndrome. We assessed pathogenicity of variants through in silico analyses and cell-based experiments.RESULTS: We identified 20 unique, mostly de novo, ANKRD11 missense variants in 29 individuals, presenting with syndromic neurodevelopmental disorders similar to KBG syndrome caused by ANKRD11 protein truncating variants or 16q24.3 microdeletions. Missense variants significantly clustered in repression domain 2 at the ANKRD11 C-terminus. Of the 10 functionally studied missense variants, 6 reduced ANKRD11 stability. One variant caused decreased proteasome degradation and loss of ANKRD11 transcriptional activity.CONCLUSION: Our study indicates that pathogenic heterozygous ANKRD11 missense variants cause the clinically recognizable KBG syndrome. Disrupted transrepression capacity and reduced protein stability each independently lead to ANKRD11 loss-of-function, consistent with haploinsufficiency. This highlights the diagnostic relevance of ANKRD11 missense variants, but also poses diagnostic challenges because the KBG-associated phenotype may be mild and inherited pathogenic ANKRD11 (missense) variants are increasingly observed, warranting stringent variant classification and careful phenotyping.
AB - PURPOSE: Although haploinsufficiency of ANKRD11 is among the most common genetic causes of neurodevelopmental disorders, the role of rare ANKRD11 missense variation remains unclear. We characterized clinical, molecular, and functional spectra of ANKRD11 missense variants.METHODS: We collected clinical information of individuals with ANKRD11 missense variants and evaluated phenotypic fit to KBG syndrome. We assessed pathogenicity of variants through in silico analyses and cell-based experiments.RESULTS: We identified 20 unique, mostly de novo, ANKRD11 missense variants in 29 individuals, presenting with syndromic neurodevelopmental disorders similar to KBG syndrome caused by ANKRD11 protein truncating variants or 16q24.3 microdeletions. Missense variants significantly clustered in repression domain 2 at the ANKRD11 C-terminus. Of the 10 functionally studied missense variants, 6 reduced ANKRD11 stability. One variant caused decreased proteasome degradation and loss of ANKRD11 transcriptional activity.CONCLUSION: Our study indicates that pathogenic heterozygous ANKRD11 missense variants cause the clinically recognizable KBG syndrome. Disrupted transrepression capacity and reduced protein stability each independently lead to ANKRD11 loss-of-function, consistent with haploinsufficiency. This highlights the diagnostic relevance of ANKRD11 missense variants, but also poses diagnostic challenges because the KBG-associated phenotype may be mild and inherited pathogenic ANKRD11 (missense) variants are increasingly observed, warranting stringent variant classification and careful phenotyping.
U2 - 10.1016/j.gim.2022.06.007
DO - 10.1016/j.gim.2022.06.007
M3 - Article
C2 - 35833929
SN - 1098-3600
VL - 24
SP - 2051
EP - 2064
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 10
ER -